Welcome to our dedicated page for ENvue Medical news (Ticker: FEED), a resource for investors and traders seeking the latest updates and insights on ENvue Medical stock.
ENvue Medical develops medical technology for enteral care, with a commercial focus on real-time guided bedside feeding tube placement. Its ENvue Navigation Platform is an FDA 510(k)-cleared electromagnetic navigation system for adult use that provides visual guidance as clinicians place feeding tubes into the gastrointestinal tract.
Company news commonly covers hospital adoption, group purchasing and distribution agreements, commercialization updates, and product-line expansion for ENFit syringes and enteral supplies. Updates also include intellectual-property activity tied to feeding tube navigation and the company's surface acoustic wave platform, including acoustic therapeutic technologies such as PainShield and UroShield for pain, bacterial colonization, and biofilm-related applications.
ENvue Medical (NASDAQ: FEED) launched Ask Oscar, an AI-powered training platform for its ENvue Navigation feeding tube system. The tool lets clinicians train independently with real-time guidance and performance feedback, aiming to accelerate platform adoption and create scalable recurring revenue, while forming a foundation for future robotic-assisted ENvue Drive applications.
A peer-reviewed study of the ENvue Navigation Platform reported zero lung placements in 531 procedures, a 67% drop in ventilator-associated pneumonia, a 4,320% rise in post-pyloric feeding access, over 350 nursing hours saved annually and more than $1.5 million in annual cost avoidance in one health system.
ENvue Medical (NASDAQ: FEED) announced expansion of its ENvue Navigation Platform into an American Burn Association-verified burn intensive care unit within a major U.S. academic health network, marking a second deployment in the same system.
The bedside system helps clinicians place and confirm feeding tube position in real time and is currently deployed across 40 U.S. hospitals.
ENvue Medical (NASDAQ: FEED) reported an independent, peer-reviewed study from Inova Health System showing major safety and cost benefits from the ENvue Navigation Platform.
Across five hospitals and 531 placements, Inova saw a 67% drop in ventilator-associated pneumonia, no lung misplacements, 350+ nursing hours saved, 20% fewer X-rays, and an estimated $1.5 million in avoided costs in year one.
ENvue Medical (NASDAQ: FEED) will exhibit its ENvue™ Navigation Platform at the AACN NTI 2026 conference in Denver on May 21–22, 2026.
The FDA 510(k)-cleared electromagnetic system supports real-time guided bedside feeding tube placement and aligns with hospitals’ focus on workflow efficiency, nursing-led care, and patient safety.
ENvue Medical (NASDAQ: FEED) announced a three-year contract renewal with a leading integrated nonprofit health system operating 12 hospitals in Virginia and North Carolina. The ENvue Navigation Platform has been adopted as the standardized protocol for bedside enteral feeding tube placement across the entire network, embedding the technology into clinical workflow through 2028.
ENvue Medical plans to use this systemwide standardization as a model to pursue similar adoption across additional U.S. health systems.
ENvue Medical (NASDAQ: FEED) received a USPTO Notice of Allowance for U.S. Patent Application No. 17/025,969 on May 8, 2026, covering a surface acoustic wave (SAW) ultrasound-enhanced system for transdermal delivery of cannabinoid therapeutics.
The allowed claims span transdermal patch configurations, portable SAW-generating platforms, and methods that the company says produce synergistic enhancement of cannabinoid skin absorption versus patch-only administration. The company says the allowance broadens its IP footprint and could enable future collaborations and applications beyond existing marketed products.
ENvue Medical (NASDAQ: FEED) announced a three-year purchasing agreement renewal with a Group Purchasing Organization covering one of the largest U.S. non-profit health systems operating over 90 hospitals in 17 states. The contract secures contracted access through 2028, simplifying procurement and enabling faster adoption across the network.
The company said the renewal reduces facility-level procurement hurdles and creates a multi-year commercial foundation to drive broader utilization and expand its installed base.
ENvue Medical (NASDAQ: FEED) announced a Virginia 255-bed nonprofit medical center affiliated with the Mayo Clinic Care Network adopted the ENvue™ Navigation Platform, marking ENvue's 40th U.S. hospital customer.
The hospital shifted feeding tube placement from interventional radiology to a nursing-led bedside model using ENvue's FDA 510(k)-cleared electromagnetic navigation for real-time visualization.
ENvue Medical (NASDAQ: FEED) issued a stockholder letter outlining 2025 progress and 2026 priorities. The company reports commercial deployment of its ENvue Navigation Platform across 39 U.S. hospitals, recurring consumable revenue, a February 2026 USPTO Notice of Allowance for a combined electromagnetic-navigation and distal-tip camera feeding tube, and UK reimbursement for UroShield.
Key 2026 priorities include accelerating U.S. commercial adoption, pursuing pediatric and PICC clearances, expanding at-home ENFit syringe distribution, and advancing acoustic therapeutics.
ENvue Medical (NASDAQ: FEED) announced a hospital purchase that expands its U.S. hospital footprint to 39 hospitals by adding a 714-bed teaching hospital and Level I Trauma Center in the Detroit metro area.
The purchase includes the ENvue™ Navigation Platform and feeding tubes; the platform is FDA 510(k) cleared for adult use and provides real-time bedside visualization to assist clinicians during enteral feeding tube placement.